Charles Zhou
Stock Analyst at Guggenheim
(2.95)
# 1,325
Out of 5,174 analysts
8
Total ratings
83.33%
Success rate
45.95%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Charles Zhou
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COGT Cogent Biosciences | Maintains: Buy | $17 → $20 | $34.96 | -42.79% | 2 | Aug 25, 2025 | |
| FUTU Futu Holdings | Maintains: Buy | $130 → $136 | $140.29 | -3.06% | 3 | Mar 17, 2025 | |
| ZYME Zymeworks | Reiterates: Buy | $16 | $23.60 | -32.20% | 1 | Mar 8, 2023 | |
| MGNX MacroGenics | Downgrades: Neutral | n/a | $2.73 | - | 1 | May 5, 2022 | |
| PMVP PMV Pharmaceuticals | Initiates: Buy | $56 | $1.39 | +3,928.78% | 1 | Aug 2, 2021 |
Cogent Biosciences
Aug 25, 2025
Maintains: Buy
Price Target: $17 → $20
Current: $34.96
Upside: -42.79%
Futu Holdings
Mar 17, 2025
Maintains: Buy
Price Target: $130 → $136
Current: $140.29
Upside: -3.06%
Zymeworks
Mar 8, 2023
Reiterates: Buy
Price Target: $16
Current: $23.60
Upside: -32.20%
MacroGenics
May 5, 2022
Downgrades: Neutral
Price Target: n/a
Current: $2.73
Upside: -
PMV Pharmaceuticals
Aug 2, 2021
Initiates: Buy
Price Target: $56
Current: $1.39
Upside: +3,928.78%